Rick Theis

Measures and policies related to increasing and enhancing the wages and retirement security support for SEIU members, especially Personal Support Workers. Ensuring the Safe Long Term Care Act, which has yet to be introduced, reflects support for the health, safety and working conditions of front line health care workers.

Enhancing global market access for Alberta exports by expanding pipeline access to tidewater, including through the removal of the Tanker Ban, investing in trade-related transportation infrastructure, and addressing internal trade barriers. Supporting the federal government's defence and economic security priorities by exploring opportunities for Alberta to strengthen Canada's defence industrial base, attract investment, and contribute to resilient supply chains and strategic infrastructure. Exploring opportunities to support the federal government's One Canadian Economy agenda through greater economic integration, reduced interprovincial trade barriers, and strengthened collaboration on nation-building projects. Supporting a strong Alberta within a united Canada by exploring policies that address fairness in the federation, strengthen Alberta’s economic contribution, and improve federal-provincial collaboration on shared priorities. Exploring strategies to support economic growth in Alberta and Canada while ensuring long-term fiscal sustainability and broad-based prosperity. Providing an update on the Business Council of Alberta’s priorities, including productivity, competitiveness, labour shortages, infrastructure, and housing, and identifying opportunities to collaborate with the federal government on advancing shared policy goals. Attracting investment to Alberta and Canada by exploring ways to address regulatory barriers to business investment and create a competitive business landscape. Proposing amendments to the new greenwashing provisions which, as written, will undermine Canadian businesses’ ability to raise capital, take risks, innovate, and make good-faith environmental progress in uncertain conditions. The federal government should respect the CRTC’s Fibre to the Premise decision, which supports a more competitive telecommunications sector and reinforces regulatory autonomy, a principle that is key to investor confidence and a dynamic business environment across all sectors of the Canadian economy. Federal natural resources and environment policy. Unlocking investment and growth in Canada's natural resource industries, and how they can contribute to Canada's productivity, prosperity, and environmental goals. Discriminatory and/or counterproductive impacts on Alberta and Alberta-concentrated industries. Maintaining access to US markets in the face of tariff threats and CUSMA renewal. Discussing how issues related to defence spending, border crossings and illegal drug/gun trafficking impact trade and trade policy. Preserving and enhancing Canada’s access to trade opportunities in global markets; addressing trade disputes, including the differing impact of those disputes across Canada. Exploring opportunities to increase economic activity and value-added processing in agriculture; and discussing the removal of barriers to achieving that goal. Expressing our opposition to the proposed emissions cap as being bad for the environment, the economy, the federation, and Canada’s international standing. Improving Canada's system of major project approvals and permitting to allow projects to get built faster, generate economic growth and advance Indigenous Economic Diversification. Issues range from speeding up environmental impact assessments, to removing fed/prov duplication, to better coordinating permitting processes across the federal government. Removing barriers to interprovincial trade. Providing information via our "Alberta Update" to senior government officials on economic developments in the province. Exploring ways to improve co-operation and collaboration between the federal and provincial governments. The merits and drawbacks of the federal government's proposed oil and gas sector emissions cap; and the most efficient, cost-effective ways to promote a competitive energy sector in Alberta while working towards deep emissions cuts. Proposing amendments to the Clean Electricity Regulations that reflect the concerns

Implementation of the Homelessness Reduction Innovation Fund Expand funding for community efforts to address homelessness through Reaching Home and make changes to the National Housing Strategy, Reaching Home, and federal housing policy to support ending homelessness and the implementation of the right to housing in Canada. Seeking to secure federal government investment in affordable and supportive housing for Canadians experiencing or at risk of homelessness and expand housing options for people at risk of or experiencing homelessness through Build Canada Homes. Policies and investments in support of ending homelessness in Budget 2026 Taxation relating to Canadian charities Seeking program and policy changes from Women and Gender Equity to address housing need and homelessness for women. Seeking program and policy changes from Veterans Affairs Canada and Housing Infrastructure and Communities Canada to support federal action on ending homelessness for veterans. Seeking funding support for National Conference on Ending Homelessness, funding to support work to prevent and reduce homelessness as well as funding for research on homelessness and housing need in Canada, through Reaching Home (HICC); Veterans Affairs Canada; Canada Mortgage Housing Corporation; and Women & Gender Equality, to support research on homelessness for women and advancing the right to housing. Encouraging the implementation of housing policies in alignment with the human right to housing and National Housing Strategy Act

To advocate for a refund mechanism to be included in future legislation required to repeal the consumer price on carbon. To create a specified Low Carbon Intensity Fuel Infrastructure fund that provides non-repayable grants and/or expand Clean Technologies Investment Tax Credit to capital investements for renewable fuel storage. Arrange meetings with Parliamentarians about the Government of Canada's engagement on Framework Development for Fuel, Alcohol, Cannabis and Tobacco Sales Tax Arrangements with Interested Indigenous Governments

Advocating to the Federal Government on the application and proposing amendments to the Prohibition on the Purchase of Residential Property by Non-Canadians Act.

Implementation of federal single-use plastics regulations. Creation of a National Plastics Registry Matters relating to investment climate, circular economy, climate change, environmental stewardship, recycling and labour issues. Bill S-5, An Act to amend the Canadian Environmental Protection Act, 1999, to make related amendments to the Food and Drugs Act and to repeal the Perfluorooctane Sulfonate Virtual Elimination Act U.S.-Canada Regulatory Cooperation Council (the Council “provides a forum for stakeholders, including industry, consumers, and non-government organizations, to discuss regulatory barriers and identify opportunities for regulatory cooperation between the United States and Canada.)

The government's economic, health, investment, science and technology, and trade policies as they relate to the pharmaceutical industry. Free trade treaty agreement as it relates to the Canada/US Free Trade Agreement and free trade negotiations as it relates to Columbia, India, and the European Union. Patented Medicine Notice of Compliance (PMNOC) Regulations - enforcement of Intellectual Property with respect to the Canadian pharmaceutical industry. Patent Act - An Act respecting patents of invention with regard to Intellectual Property Protection for pharmaceutical products - federal court decisions that have changed the disclosure requirements regarding the utility of an invention. Intellectual Property - Changes to Patented Medicine (Notice of Compliance) (PMNOC) regulations - important regulations that can affect Eli Lilly's business. Pharmaceutical pricing policy arising from the jurisdiction of the Patented Medicines Prices Review Board (PMPRB). Pharmaceutical and trade policy as it relates to security of supply for Canadian medicines. Patented Medicines Prices Review Board (PMPRB) proposed regulations, in regards to pharmaceutical pricing policy. C-64, An act respecting pharmacare - discussions around the structuring and implementation of a national pharmacare program. Food and Drug Act - An Act respecting food, drugs, cosmetics and therapeutic devices. Discussions relating to progressive licensing and the modernization of the Food & Drug Act.

Informing officials of the unique impacts on the hospitality sector; advocating for government supports to increase tourism's potential to drive economic growth and job creation in all regions of the country by engaging on topics including immigration, transportation, training, infrastructure investments, and regional supports

Transportation - proposed new international bilateral air routes with Canada. Consideration of airport rents at formerly owned federal airports across Canada. Tourism - Canadian Tourism Commission Budget as announced in the 2010 Federal Budget. Development of the proposed Federal Tourism Strategy as announced by the Prime Minister in June 2009. Taxation and Finance - Ammendments to the Foreign Convention Tour and Incentive Program. Regulations and policies regarding fees to SOCAN and Re:Sound Immigration Canada - Support for Temporary Foreign Workers Program. Engage with the Federal Government on proposed new or amended taxation laws with respect to short-term accommodations. Employment and Training - Support for the Temporary Foreign Workers Program. Criminal Code regulations pertaining to impaired driving Coronavirus (COVID-19) Pandemic - Seeking changes on EI reform. Ensuring access to financial impact measures. Monitoring developments and assessing impacts on members.

Advocacy on the creation of the Health Emergency Readiness Canada (HERC) Agency Contribution to the Government Public consultations on Canada-United States-Mexico Agreement to inform Canada’s priorities in preparation for the first joint review of CUSMA by Canada, the United States and Mexico in 2026 and ahead of Canada’s chairing of the 5th meeting of the CUSMA Free Trade Commission, in 2025. Advocacy on the proposed Regulations Amending the Patent Rules and Certain Regulations Made Under the Patent Act which were published for consultation in Canada Gazette Part I (CGI) on May 18, 2024.1 Share concerns with Canada’s implementation of a patent term adjustment (PTA) system that is not compliant with its trade obligations, as it does not provide a meaningful remedy to patentees who are impacted by unreasonable patent office delays. The Department of Innovation, Science and Economic Development and the Innovation Agenda for the life sciences sector: policy or program initiatives to support life science research and development conducted in Canada and manufacturing capability. Regulations, policies and programs related to the reimbursement recommendations decision-making process and framework done by the Canadian Drug Agency as well as the review times and processes conducted by Health Canada for the purpose of obtaining a notice of compliance. Patented Medicine Prices Review Board (PMPRB) amendments to the Patented Medicines Regulations and the related proposed guidelines. Monitoring and engaging the Government and Parliamentarians on the House of Commons Standing Committee on Public Accounts (PACP) motion related to the discloser on vaccine contracts Monitoring and engaging the Government and Parliamentarians on policies and programs related to Canada's life sciences & biomanufacturing strategy Monitoring and engaging on the Government’s commitment to create a national strategy for rare diseases; the Canadian Drug Agency; and C64, An Act to Implement pharmacare. Health Canada’s policies, program and guidelines related to the management, prevention, mitigation and notification of drug shortages Federal Public Drug Plans, with respect to the reimbursement of therapeutic products for Federal plan beneficiaries Engage the Federal Government on Health Canada’s Regulatory Innovation Agenda (Agile Licensing Modernization) to discuss opportunities for further harmonization; flexibility and predictability in the new regulatory framework being develop and its linkage to pillar 5 of the Biomanufacturing and Life Sciences Strategy. Discussions on the procurement of a COVID19 vaccine and therapy Discussions around the World Trade Organization consideration of a TRIPS Patent Waiver and the World Health Organization pandemic treaty proposal Consider amendments to the Food and Drugs Act, or the Export and Imports Permits Act (Export Control List) or any other legislative and regulatory means in order to protect the Canadian supply of drugs in light of potential importation legislation in the United States. Advocacy to maintain and increase funding for the National Immunization Strategy and discussions on vaccine procurement.